TDOC Teladoc Health, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Teladoc Health, Inc. (TDOC) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 26, 2026, a 10-Q quarterly report filed on October 30, 2025, an 8-K current report filed on April 29, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Teladoc Health, Inc. (TDOC) (SEC CIK 1477449), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business model: Global virtual care leader offering integrated healthcare services via technology platforms to employers, health plans, and individuals
- • New emphasis on AI-enhanced capabilities: Advanced AI-driven predictive analytics, personalized engagement, and AI-enabled clinical documentation improvements launched in Prism platform
Risk Factors
- • Regulatory risk: Impact of Patient Protection and Affordable Care Act (PPACA) and related laws reducing Medicare payments up to 2% annually through 2030
- • Geopolitical/macroeconomic threat: Revenue risk from potential Client mergers/acquisitions causing contract cancellations or non-renewals impacting 19% total revenue from top five Clients
Management Discussion & Analysis
- • Revenue details for FY2025 vs FY2024 omitted; see 2024 10-K filed Feb 27, 2025 for full YoY analysis
- • U.S. Integrated Care members +9% YoY, increased by 8.0 million to 101.8 million as of Dec 31, 2025
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Risk Factors
- • New operational risk: CFO Mala Murthy resignation effective Nov 21, 2025, CEO Charles Divita to serve as interim principal financial officer
- • Financial risk update: Credit Agreement dated July 17, 2025, with JPMorgan Chase Bank as administrative agent executed July 23, 2025
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full-year 2025 earnings released Feb 25, 2026 — full financials in Exhibit 99.1
- • Investor focus: TDOC has faced significant revenue pressure and goodwill impairment charges in recent years; results signal trajectory of turnaround or continued decline
Annual Reports Archive10-K
AI-powered analysis of Teladoc Health, Inc. (TDOC) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of Teladoc Health, Inc. (TDOC) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Teladoc Health, Inc. (TDOC) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $2.4B | $2.6B | $2.6B | $2.5B |
| Operating Income | -$13.7B | -$248.6M | -$1.0B | -$263.0M |
| Net Income | -$13.7B | -$220.4M | -$1.0B | -$200.3M |
| Op. Margin | -567.3% | -9.6% | -39.7% | -10.4% |
| Net Margin | -567.5% | -8.5% | -39.0% | -7.9% |
| Balance Sheet | ||||
| Total Assets | $4.3B | $4.4B | $3.5B | $2.9B |
| Equity | $2.3B | $2.3B | $1.5B | $1.4B |
| ROE | -591.9% | -9.5% | -67.1% | -14.5% |
Source: XBRL financial data from Teladoc Health, Inc. (TDOC) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 29, 2026 | — | — | — |
8-K | Mar 30, 2026 | — | — | — |
10-K | Feb 26, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 25, 2026 | — | Analysis | — |
8-K | Feb 18, 2026 | — | — | |
8-K | Feb 12, 2026 | — | — | |
8-K | Dec 16, 2025 | — | — | |
8-K | Dec 12, 2025 | — | — | |
10-Q | Oct 30, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Jul 30, 2025 | Jun 30, 2025 | — | |
10-Q | May 1, 2025 | Mar 31, 2025 | — | |
10-K | Feb 27, 2025 | Dec 31, 2024 | — | |
10-Q | Oct 31, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 1, 2024 | Jun 30, 2024 | — | |
10-Q | Apr 26, 2024 | Mar 31, 2024 | — | |
10-K | Feb 23, 2024 | Dec 31, 2023 | — | |
10-Q | Oct 27, 2023 | Sep 30, 2023 | — | |
10-Q | Jul 28, 2023 | Jun 30, 2023 | — | |
10-Q | May 2, 2023 | Mar 31, 2023 | — | |
10-K | Mar 1, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 2, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 3, 2022 | Jun 30, 2022 | — | |
10-Q | May 2, 2022 | Mar 31, 2022 | — | |
10-K | Feb 28, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 1, 2021 | Sep 30, 2021 | — |
Frequently Asked Questions
What are the latest TDOC SEC filings in 2026?
Teladoc Health, Inc. (TDOC) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on October 30, 2025, an 8-K current report on April 29, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did TDOC file its most recent 10-K annual report?
Teladoc Health, Inc. (TDOC) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view TDOC 10-Q quarterly reports?
Teladoc Health, Inc. (TDOC)'s most recent 10-Q quarterly report was filed on October 30, 2025. SignalX displays every TDOC 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has TDOC filed recently?
Teladoc Health, Inc. (TDOC)'s most recent 8-K was filed on April 29, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find TDOC insider trading activity (Form 4)?
SignalX aggregates every TDOC Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does TDOC file with the SEC?
Teladoc Health, Inc. (TDOC) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new TDOC filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Teladoc Health, Inc. (TDOC).
What is TDOC's SEC CIK number?
Teladoc Health, Inc. (TDOC)'s SEC CIK (Central Index Key) number is 1477449. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1477449 to look up all TDOC filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find TDOC return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Teladoc Health, Inc. (TDOC) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Teladoc Health, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 31+ filings.